In re: Clovis Oncology, Inc. Lead Case No: 22-11292 (JKS) Unaudited Balance Sheet as of
May 31, 2023 Reporting Period: May 01May 31, 2023 Clovis Oncology UK Clovis Oncology Ireland Clovis Oncology, Inc. USD Actuals Limited Limited Assets Current
Assets: Cash and Cash Equivalents 125,901,215 6,632,201 2,433,588 Trade Accounts Receivable, Net 1,715,811 1,574,298Interco Receivables 23,824,280 350 21,431,258
Pre-PetitionInter Company Debtor Receivables Inventories Prepayments and Deposits 14,406,182 126,030 3,408 Other AssetsCurrent 226,394 2,316,152 880,183 IC Investment in Subsidiaries 2
229,143 Total Current Assets 166,073,884 10,878,173 24,748,437 Non-Current Assets: Property, Plant and Equipment, Net 127,026 108,828Goodwill 63,074,218 Other
Intangible Assets, Net Other AssetsNon-current 4,813,211 135,705 25,949 Total Non-Current Assets 68,014,455 244,533 25,949 Total Assets 234,088,339
11,122,706 24,774,386 Liabilities Current Liabilities: DIP Financing 5,276,243 Trade Accounts Payable, Net 4,798,437 13,551 10,925 Interco Payables 7,914,715 5,833,625 18,291,125 Misc.
Liabilities & Accrued Expenses 21,137,559 2,635,098 184,128 Accrued Taxes (Income, Payroll, etc.) (16,203) 1,110,406 272,309 Lease LiabilityShort-term 49,700 113,932 17,497 Other Notes PayableCurrent Total Current
Liabilities 39,160,451 9,706,613 18,775,983 Non-Current Liabilities Lease LiabilityLong-term 6,748 Total Non-Current Liabilities
6,748 Liabilities Subject to Compromise 822,895,943 778,509 21,778 Total Liabilities 862,056,394 10,485,122 18,804,510 Equity Common Stock 145,470 2 141 Additional Paid in Capital 2,691,516,957 Accumulated Other
Comprehensive Loss (41,905,090) (461,115) 27,615 Accumulated Deficit (3,277,725,392) 1,098,698 5,942,121 Total Equity (627,968,055) 637,584 5,969,877 Total Liabilities and Equity 234,088,339 11,122,706 24,774,386 Notes: 1) The financial statements
and supplemental information contained herein are limited in scope and cover a limited time period. Moreover, such information is preliminary, unaudited, and subject to change. #AlixPartners General